Ceftriaxone compared with cefotaxime for serious bacterial infections

Craig R. Smith, Brent Gray Petty, Craig Hendrix, Walter N. Kernan, Patty L. Garver, Kevin Fox, Andrew Beamer, Kathy Carbone, Michael Threlkeld, Paul S. Lietman

Research output: Contribution to journalArticle


Ceftriaxone was compared with cefotaxime for the treatment of serious bacterial infections in a prospective, randomized, double-blind clinical trial. The dose of ceftriaxone was 2 g once a day, and the dose of cefotaxime was 2 g every 4 h. Metronidazole was added if anaerobic infection was suspected. Explicit criteria were used to define infections, clinical response, and adverse effects. Ceftriaxone wasgiven to 88patients and cefotaxime to 83. The two treatment groups did not differ in types of infection, infecting organisms, and severity of underlying disease. The response rate was 81070 (71/88) for ceftriaxone and 80% (66/83) for cefotaxime. The power of the study to detect a 15% difference in response rate at P

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalJournal of Infectious Diseases
Issue number3
Publication statusPublished - 1989


ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this